Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MDGL compared with KYMR: revenue, margins and what each company keeps, and the suppliers and customers both name
MDGL
Madrigal Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
KYMR
Kymera Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MDGL
Madrigal Pharmaceuticals, Inc.
vs
KYMR
Kymera Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MDGL, solid
KYMR, dashed
MDGL
Madrigal Pharmaceuticals, Inc.
Change
430.17
· pre 430.00
Mkt cap
$9.9B
Revenue
$364M
Q2 FY26
Revenue
$958M
FY25
KYMR
Kymera Therapeutics, Inc.
Change
126.75
· pre 128.98
Pre-market
Sep 2 '83
Mkt cap
$10.8B
Revenue
$65M
Q2 FY26
Revenue
$39M
FY25
vs
Compare
Pre-market
Sep 2 '83
MDGL
Madrigal Pharmaceuticals, Inc.
vs
KYMR
Kymera Therapeutics, Inc.
430.17
pre 430.00
Price
126.75
pre 128.98
$9.9B
Mkt cap
$10.8B
Q2 FY26
$364M
Revenue
$65M
Q2 FY26
FY25
$958M
Revenue
$39M
FY25
Change
Change
MDGL
430.17
vs
KYMR
126.75
Pre-market
Sep 2 '83